If so, do you have a suggestion for a medication that would be a good candidate to make the switch
With GLP-1 receptor agonists in the mix, glucagon secretion takes a back seat, leading to a decrease in glucose production in the liver
Bile acid malabsorption, diarrhea, and fat intolerance after gallbladder removal can closely resemble GLP-1 gastrointestinal side effects, and without a pre-treatment amylase and lipase reading there is nothing to compare a later result against
This is consistent with other metabolic diseases, including hypertension, diabetes, and high cholesterol levels
If future research continues to support the heart and kidney benefits seen in current trials, GLP-1 medicines could become part of a broader strategy aimed not only at managing disease but potentially delaying some of its most serious consequences